Αποτελέσματα Αναζήτησης
This narrative review uses data from network meta-analyses and systematic reviews to explore the prevalence, diagnosis, and treatment of major depression
The Agency for Healthcare Research and Quality (AHRQ) has requested a review on screening and treatment for depression, anxiety disorders, and suicide risk in adults, including pregnant people.
17 Φεβ 2020 · Depressive disorders are common, costly, have a strong effect on quality of life, and are associated with considerable morbidity and mortality. Effective treatments are available: antidepressant medication and talking therapies are included in most guidelines as first-line treatments.
Screening programs generally increased the likelihood of remission and treatment response in general adult populations (k=5) experiencing depressive symptoms, but typically included additional treatment supports.
15 Μαρ 2021 · We conducted a systematic review and meta-analysis of all studies using MRI to predict single-subject response to antidepressant treatment in patients with MDD.
This narrative review will focus on novel and emerging treatments for MDD (at any stage of the treatment cycle, from initial episode through to failure to respond to treatment) and their effectiveness, safety, and applicability in real world settings.
Depression among hospitalized patients is often unrecog-nized, undiagnosed, and therefore untreated. Little is known about the feasibility of screening for depression during hos-pitalization, or whether depression is associated with poor-er outcomes, longer hospital stays, and higher readmission rates.
